The receptors expressed by the tumors developed in vivo were not assessed, so EGF-conjugated GNPs were used as a potential more targeted tool for tumor cells in comparison to healthy cells, based on the increased expression of EGFR in tumor cells reported in literature [61]. Here, EGF is linked to neoplasm.